FormDSignal
47

Iambic Therapeutics, Inc. raises $27.8M under Reg D

Company raise · Raising · SAN DIEGO, CA · Form D filed 2026-04-08
$10M+ raise

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Shalini SharpDirector
R. Jacob VogelsteinDirector
Thomas MillerExecutive Officer, Director
Fred ManbyExecutive Officer, Director
Michael SecoraExecutive Officer
Neil JosephsonExecutive Officer
Mary TagliaferriDirector
Kurt von EmsterDirector
William RastetterDirector
Jishnu BhattacharjeeDirector
Evan RachlinDirector
Pete OlsonExecutive Officer

Signed by Thomas Miller, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer